USPTO serial 79194043
SELENRIAV
Reviewed by CopyMark Law Group
Reg. 5158566Status 709
- Filing date
- Status date
- Registration date
- Mar 14, 2017
- Examiner
- FINK, GINA M
- Law office
- TMEG LAW OFFICE 109
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SELENRIAV?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bassam N. Ibrahim
Bassam N. Ibrahim Buchanan Ingersoll & Rooney PC1737 King StreetSuite 500Alexandria, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks in Class 005
- Similar marks named SELENRIAV
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 29, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 29, 2024 | INPC | INVALIDATION PROCESSED | — |
| Jun 14, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 29, 2023 | C71T | CANCELLED SECTION 71 | — |
| Mar 14, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 26, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 13, 2019 | A7OK | AMENDMENT UNDER SECTION 7 - PROCESSED | — |
| May 15, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 2, 2019 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| May 5, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 14, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 14, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 13, 2017 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Mar 14, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 27, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 7, 2016 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 18, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 14, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 14, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 14, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 10, 2016 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 20, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |